Gmppb-mutant mice exhibit dystroglycanopathy symptoms that are rescued with GSK3β inhibition or AAV-mediated GMPPB gene replacement
Abstract Mutations in GDP-mannose pyrophosphorylase B (GMPPB) cause dystroglycanopathy, a rare neuromuscular disorder characterized by α-dystroglycan hypoglycosylation, yet the pathogenic mechanisms and therapeutic options remain poorly defined. To dissect the molecular basis of dystroglycanopathy,...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Portfolio
2026-04-01
|
| Serija: | Nature Communications |
| Online pristup: | https://doi.org/10.1038/s41467-026-71524-7 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
